<- Go Home
10x Genomics, Inc.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Market Cap
$1.9B
Volume
1.5M
Cash and Equivalents
$398.2M
EBITDA
-$134.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$419.6M
Profit Margin
66.63%
52 Week High
$57.90
52 Week Low
$14.02
Dividend
N/A
Price / Book Value
2.63
Price / Earnings
-10.28
Price / Tangible Book Value
2.70
Enterprise Value
$1.6B
Enterprise Value / EBITDA
-13.13
Operating Income
-$171.6M
Return on Equity
24.87%
Return on Assets
-11.37
Cash and Short Term Investments
$398.2M
Debt
$85.9M
Equity
$722.8M
Revenue
$629.7M
Unlevered FCF
$97.4M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium